HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$13.99−0.41 (-2.85%)
Close on Nov 18, 2026Market cap $2.44BP/E 5.4Yield –
HUTCHMED (China) operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
HUTCHMED (China)'s operating cash flow for the twelve months ending Dec 31, 2019 was -$80.91M. For fiscal 2025 it was -$64.66M, down 13109.5% from the year before. The highest annual figure on record is $219.26M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$64.66M | -13109.5% |
| FY2024 | Dec 31, 2024 | $497.00K | -99.8% |
| FY2023 | Dec 31, 2023 | $219.26M | – |
| FY2022 | Dec 31, 2022 | -$268.60M | – |
| FY2021 | Dec 31, 2021 | -$204.22M | – |
| FY2020 | Dec 31, 2020 | -$62.07M | – |
| FY2019 | Dec 31, 2019 | -$80.91M | – |
| FY2018 | Dec 31, 2018 | -$32.85M | – |
| FY2017 | Dec 31, 2017 | -$8.94M | – |
| FY2016 | Dec 31, 2016 | -$9.57M | – |
| FY2015 | Dec 31, 2015 | -$9.39M | -212.3% |
| FY2014 | Dec 31, 2014 | $8.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | -$17.39M | – |
| Q3 FY2019 | Sep 30, 2019 | -$33.48M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.12M | -109.2% |
| Q1 FY2019 | Mar 31, 2019 | -$28.92M | – |
| Q4 FY2018 | Dec 31, 2018 | -$13.94M | – |
| Q3 FY2018 | Sep 30, 2018 | -$315.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $12.24M | – |
| Q1 FY2018 | Mar 31, 2018 | -$30.84M | – |
See a number that looks wrong?